Trial intelligence / Profile preview

Perfluoropropane Albumin Microspheres for Liver Lesion Ultrasound Imaging

CTR20130075Phase 3Active

Start
Apr 2013
Modality
Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of perflutren protein type a in Liver lesion. Started Apr 2013; status: active.

02

Drugs

perflutren protein type a
03

Conditions

Liver lesion

Beyond the preview

Go deeper on CTR20130075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call